Macpod Oral Drops contain Cefpodoxime Proxetil 25 mg, a third-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. Cefpodoxime Proxetil is a prodrug that, upon oral administration, is rapidly converted to its active form, cefpodoxime, which inhibits bacterial cell wall synthesis, leading to cell lysis and death. Macpod Oral Drops are indicated for the treatment of various infections caused by susceptible strains of bacteria, including respiratory tract infections such as bronchitis and pneumonia, urinary tract infections, skin and soft tissue infections, and otitis media. The formulation is designed for ease of administration, particularly in pediatric patients or individuals with difficulty swallowing tablets. Dosage should be determined based on the severity of infection, patient age, and renal function, adhering to prescribed guidelines to reduce the risk of resistance development. Common side effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort, while hypersensitivity reactions are rare but possible. Macpod Oral Drops should be used with caution in patients with a history of penicillin or cephalosporin allergy. It is essential to complete the full prescribed course to ensure eradication of the infection and prevent recurrence.